Evidence map›Paper›PMID 32365089›Full record

ArticlePLoS computational biology2020

Association test using Copy Number Profile Curves (CONCUR) enhances power in rare copy number variant analysis.

Amanda Brucker, Wenbin Lu, Rachel Marceau West, Qi-You Yu, Chuhsing Kate Hsiao, Tzu-Hung Hsiao, Ching-Heng Lin, Patrik K E Magnusson, Patrick F Sullivan, Jin P Szatkiewicz and 2 more

Open access · goldAbstract read
In one paragraph

Article in PLoS computational biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Genetic and epigenetic signatures associated with plasma oxytocin levels in children and adolescents with autism spectrum disorder.Autism research : official journal of the International Society for Autism Research · 2023
    Trial
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Amanda BruckerDepartment of Statistics, North Carolina State University, Raleigh, North Carolina, United States of America.ORCID 0000-0002-9966-3001
Wenbin LuDepartment of Statistics, North Carolina State University, Raleigh, North Carolina, United States of America.
Rachel Marceau WestDepartment of Statistics, North Carolina State University, Raleigh, North Carolina, United States of America.
Qi-You YuInstitute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan.
Chuhsing Kate HsiaoInstitute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan.ORCID 0000-0003-4905-8484
Tzu-Hung HsiaoDepartment of Medical Research, Taichung Veterans General Hospital, Taiwan.
Ching-Heng LinDepartment of Medical Research, Taichung Veterans General Hospital, Taiwan.
Patrik K E MagnussonDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet SE-171 77 Stockholm, Sweden.ORCID 0000-0002-7315-7899
Patrick F SullivanDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet SE-171 77 Stockholm, Sweden.
Jin P SzatkiewiczDepartment of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Tzu-Pin LuInstitute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan.ORCID 0000-0003-3697-0386
Jung-Ying TzengDepartment of Statistics, North Carolina State University, Raleigh, North Carolina, United States of America.ORCID 0000-0002-5505-1775
North Carolina State University · USNational Taiwan University · TWTaichung Veterans General Hospital · TWUniversity of North Carolina at Chapel Hill · USKarolinska Institutet · SE

Funding

Statistical Methods for Cancer Clinical TrialsP01CA142538 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KOSOROK, MICHAEL R · 2010 to 2019
$21.3M
Finding causal variants within schizophrenia risk lociR01MH106611 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SZATKIEWICZ, JIN PENG · 2015 to 2019
$3.3M
Biostatistics Training in the Omics EraT32GM081057 · NIGMS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI MUSE, SPENCER V. · 2007 to 2019
$2.5M
Finding single-gene copy number variants in schizophreniaR21MH104831 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CROWLEY, JAMES JOSEPH, SZATKIEWICZ, JIN PENG · 2014 to 2015
$418k
NCI NIH HHS P01 CA142538NIGMS NIH HHS T32 GM081057NIMH NIH HHS R01 MH106611NIMH NIH HHS R21 MH104831
6 · The paper itself

Abstract

Copy number variants (CNVs) are the gain or loss of DNA segments in the genome that can vary in dosage and length. CNVs comprise a large proportion of variation in human genomes and impact health conditions. To detect rare CNV associations, kernel-based methods have been shown to be a powerful tool due to their flexibility in modeling the aggregate CNV effects, their ability to capture effects from different CNV features, and their accommodation of effect heterogeneity. To perform a kernel association test, a CNV locus needs to be defined so that locus-specific effects can be retained during aggregation. However, CNV loci are arbitrarily defined and different locus definitions can lead to different performance depending on the underlying effect patterns. In this work, we develop a new kernel-based test called CONCUR (i.e., copy number profile curve-based association test) that is free from a definition of locus and evaluates CNV-phenotype associations by comparing individuals' copy number profiles across the genomic regions. CONCUR is built on the proposed concepts of "copy number profile curves" to describe the CNV profile of an individual, and the "common area under the curve (cAUC) kernel" to model the multi-feature CNV effects. The proposed method captures the effects of CNV dosage and length, accounts for the numerical nature of copy numbers, and accommodates between- and within-locus etiological heterogeneity without the need to define artificial CNV loci as required in current kernel methods. In a variety of simulation settings, CONCUR shows comparable or improved power over existing approaches. Real data analyses suggest that CONCUR is well powered to detect CNV effects in the Swedish Schizophrenia Study and the Taiwan Biobank.

Indexed as

AlgorithmsArea Under CurveComputational BiologyDNA Copy Number VariationsGenetic Predisposition to DiseaseGenetic VariationGenome, HumanGenome-Wide Association StudyGenomicsHumansPolymorphism, Single NucleotideSpatial Analysis

Identifiers

PMID32365089
PMCPMC7224564
OpenAlexW3021029003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.